<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02262442</url>
  </required_header>
  <id_info>
    <org_study_id>14-074</org_study_id>
    <secondary_id>EK 177/14</secondary_id>
    <nct_id>NCT02262442</nct_id>
  </id_info>
  <brief_title>Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer During the Bronchoscopy</brief_title>
  <acronym>EnkAtomizerII</acronym>
  <official_title>Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer on Usage of Anaesthetics and Sedatives During the Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective study is to examine the benefits and risks of administration of
      local anaesthetics with a special atomizing set (Enk Fiberoptic Atomizer, Cook Medical)
      during flexible bronchoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of anaesthetics during flexible bronchoscopy</measure>
    <time_frame>one hour</time_frame>
    <description>Validation of the total amount of administered propofol (mg) during the flexible bronchoscopy.
Usage of sedatives other than propofol (midazolam), total amount of administered lidocaine, duration of bronchoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pCO2</measure>
    <time_frame>two hours</time_frame>
    <description>Determination of:
maximum transcutaneous pCO2 during bronchoscopy, mean transcutaneous pCO2 during bronchoscopy, capillary pCO2 immediately after bronchoscopy and 2 hours later, time to Aldrete Score of at least 9 after procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Flexible Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Working channel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive local anaesthetics via the working channel of the bronchoscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enk Fiberoptic Atomizer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive the local anaesthetics for the flexible bronchoscopy via the nebulizer Enk Fiberoptic Atomizer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enk Fiberoptic Atomizer</intervention_name>
    <description>Nebulization of local anesthetics with the Enk Fiberoptic Atomizer by Cook Medical during the flexible bronchoscopy</description>
    <arm_group_label>Enk Fiberoptic Atomizer</arm_group_label>
    <other_name>Enk Fiberoptic Atomizer Set, Cook Medical</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bronchoscope</intervention_name>
    <description>Standard procedure: Administration of local anesthetics via the working channel of the bronchoscope during the flexible bronchoscopy</description>
    <arm_group_label>Working channel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bronchoscopy with transbronchial biopsy or cryobiopsy indicated for diagnostic
             purposes (seed extraction in unclear infiltrates, interstitial lung disease,
             unexplained pulmonary opacities, inspection at hemoptysis)

          -  patients aged 18 years or above

          -  written informed consent prior to study participation

        Exclusion Criteria:

          -  known allergy to local anesthetics, midazolam or propofol, known epilepsy, known
             severe neurological or psychiatric disorder, hemodynamic instability with need for
             vasopressor therapy, acute or chronic decompensated heart failure, respiratory failure
             with the need for oxygen supplementation of more than 2 l per minute at rest (pO2 &gt; 55
             mmHg) or pCO2 &gt; 50 mmHg at ambient air, known upper airway anomalies, surgery or
             irradiation of the upper airways in the past, contraindication for transbronchial
             biopsy as published by international guidelines, e. g. bleeding disorders or severe
             pulmonary hypertension

          -  women, who are pregnant or breastfeeding

          -  alcohol or drug abuse

          -  expected non-compliance

          -  patients unwilling or unable to give informed consent, patients with limited ability
             to comply with instructions for this study

          -  Participation on another clinical trial within the last 3 months

          -  subjects who are committed to an institution and/or penitentiary by judicial or
             official order.

          -  employees of the investigator cooperation companies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias M端ller, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tobias M端ller, Dr. med.</last_name>
    <phone>+49 241 80 36470</phone>
    <email>tobmueller@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Habier, M.Sc.</last_name>
    <phone>+49 241 80 37429</phone>
    <email>ahabier@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine-Westphalia</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias M端ller, Dr. med.</last_name>
      <phone>+49 241 80 36470</phone>
      <email>tobmueller@ukaachen.de</email>
    </contact>
    <contact_backup>
      <last_name>Angela Habier, M.Sc.</last_name>
      <phone>+49 241 80 37429</phone>
      <email>ahabier@ukaachen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Tobias M端ller, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2014</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>flexible bronchoscopy</keyword>
  <keyword>anaesthetics</keyword>
  <keyword>transcutaneous pCO2</keyword>
  <keyword>capillary pCO2</keyword>
  <keyword>special atomizing set</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

